Study Summary
This trial suggests that for very premature infants, cycled phototherapy (PT) is better than continuous PT in terms of survival.
- Jaundice
- Premature Infants
Treatment Effectiveness
Effectiveness Progress
Study Objectives
1 Primary · 14 Secondary · Reporting Duration: Birth to 26 months corrected age
Trial Safety
Safety Progress
Trial Design
2 Treatment Groups
Continuous Phototherapy
1 of 2
Cycled Phototherapy
1 of 2
Active Control
Experimental Treatment
1700 Total Participants · 2 Treatment Groups
Primary Treatment: Phototherapy lights · No Placebo Group · Phase 3
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 22 - 27 · All Participants · 3 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
Where are the test sites for this clinical trial?
"There are 15 enrolling patients for this study such as University of Rochester in Rochester, University of Texas Southwestern Medical Center at Dallas in Dallas, and Brown University - Women and Infants Hospital of Rhode Island in Providence,to name a few 15 other locations." - Anonymous Online Contributor
Can patients that are over 30 years old join this clinical trial?
"This study is currently enrolling patients that are under 27 weeks old and over 22 weeks old." - Anonymous Online Contributor
Are there any studies that show the safety of using light therapy?
"Since this is a phase 3 trial, meaning that there is evidence of efficacy and multiple rounds of data supporting safety, we believe that the safety of phototherapy lights is a 3." - Anonymous Online Contributor
Are they looking for more individuals to participate in this clinical trial at the moment?
"The given data from clinicaltrials.gov tells us that this clinical trial is still looking for eligible patients to participate. The trial was first posted on 7/15/2020, with the most recent update being 9/26/2022." - Anonymous Online Contributor
Could I qualify to enroll in this research?
"1700 infants suffering from hyperbilirubinemia and aged between 22 and 27 weeks old can be admitted into this clinical trial. Most notably, applicants should meet the following criteria: Infants is inborn, Infant is ≤ 750 grams at birth and/or < 27 weeks gestation at birth by best OB estimate, Infant is 12-36 hours of age." - Anonymous Online Contributor